UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011364 |
|---|---|
| Receipt number | R000010965 |
| Scientific Title | Phase II study of FOLFIRI+biweekly cetuximab for KRAS wild type unresectable colorectal cancer. |
| Date of disclosure of the study information | 2013/08/03 |
| Last modified on | 2016/10/07 15:30:08 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/08/03 15:21:09 | ||
| 2 | Update | 2014/02/04 09:15:36 | TEL TEL |
|
| 3 | Update | 2016/08/05 09:35:36 | Name of primary person or sponsor Organization |
|
| 4 | Update | 2016/10/07 14:44:38 | Recruitment status Publication of results |
|
| 5 | Update | 2016/10/07 15:30:08 | Recruitment status |
